This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EZE | Ann: Appendix 5B - 30 November | 13/12/11 | 0 | 303 | |||
|
|||||||
EZE | Ann: Confirmation of Consolidation | 08/12/11 | 0 | 280 | |||
|
|||||||
EZE | Ann: Prospectus Closing Date Extended | 08/12/11 | 0 | 221 | |||
|
|||||||
EZE | Ann: Open Briefing - Chairmen Comments on Next St | 06/12/11 | 0 | 193 | |||
|
|||||||
EZE | Ann: Appendix 3B | 02/12/11 | 0 | 184 | |||
|
|||||||
EZE | Ann: New Constitution | 01/12/11 | 0 | 197 | |||
|
|||||||
EZE | Ann: Timetable for Share Consolidation | 29/11/11 | 0 | 144 | |||
|
|||||||
EZE | Ann: Results of Meeting | 28/11/11 | 0 | 144 | |||
|
See All Discussions